<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://www.peertechzpublications.org/assets/xsl/oaitohtml.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
										<responseDate>2026-05-13T12:42:11Z</responseDate>
										<request verb="GetRecord" metadataPrefix="oai_dc" identifier="oai:www.peertechzpublications.org:10.17352/sscrt.000010">https://www.peertechzpublications.org/oai-pmh</request><GetRecord><record>
								<header>
									<identifier>oai:www.peertechzpublications.org:10.17352/sscrt.000010</identifier>
									<datestamp>2016-12-31</datestamp>
									<setSpec>PTZ.SSCRT:VOL3</setSpec>
								</header>
								<metadata>
									<oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
										<dc:title>
										Comparison of 18F-FDG PET/CT and ceCT Results in the Assessment of RCC Recurrence
										</dc:title><dc:creator>Elgin OZKAN</dc:creator><dc:creator> Mine ARAZ</dc:creator><dc:creator> Cigdem SOYDAL</dc:creator><dc:creator>Gulseren ARAS</dc:creator><dc:description>&lt;p&gt;&lt;strong&gt;Aim: &lt;/strong&gt;To compare the results of fl uorine-18 (¹8F) fl uorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) and contrast enhanced computed tomography (ceCT) in the assessment of renal cell carcinoma (RCC) recurrences when ceCT had suspected lesions for local recurrence and/or distant metastases.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;A total of 22 patients (14 Male, 8 Female; mean age: 59±9 years) who were referred to perform 18F-FDG PET/CT for restaging of RCC were included in this study. All patients had suspected lesions in thoracal and/or abdominal ceCT for local recurrence and/or distant metastases before PET/CT. A retrospective analysis of the ¹8F-FDG PET/CT results was compared with ceCT results. The compatibility&amp;nbsp; ratios were calculated and accuracy of the 18F-FDG PET/CT was determined. Aggrement between 18F- FDG PET/CT and ceCT was calculated using kappa statistics.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;The overall concordance rate between the two imaging modalities was 32% (7/22 patients).The rate of concordance for local recurrence was 86% (Kappa:0.67), and for distant metastases was 68%&amp;nbsp; (Kappa:0.40). Distant metastases were also separately investigated and the two imaging methods showed a concordance of 86% (Kappa:0.70) for distant lymph node, 86% (Kappa:0.67) for lung, 91%&amp;nbsp; (Kappa:0.64) for liver and 86% (Kappa:0.33) for bone and 95% for spleen.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusion: &lt;/strong&gt;18F-FDG PET/CT is not enough alone in the detection of local recurrence and distant metastases of RCC. On the other hand, evaluation of 18F-FDG PET/CT and ceCT together signifi cantly improves the detection of RCC recurrence. A negative 18F-FDG PET/CT may contribute to exclusion of&amp;nbsp; suspected metastatic lesions, unless they are milimetric.&lt;/p&gt;</dc:description>
										<dc:publisher>Studies on Stem Cells Research and Therapy - Peertechz Publications</dc:publisher>
										<dc:date>2016-12-31</dc:date>
										<dc:type>Research Article</dc:type>
										<dc:identifier>https://doi.org/10.17352/sscrt.000010</dc:identifier>
										<dc:language>en</dc:language>
										<dc:rights>Copyright © Elgin OZKAN et al.</dc:rights>
									</oai_dc:dc>
								</metadata>
							</record></GetRecord>
						</OAI-PMH>
